grant
saveCYPRESS BIOPHARMA, INC. — Leveraging the Highly Active Metabolite of Pioglitazone as a Scaffold for a N...
September 15, 2025updated 2mo ago
community read0 votes
DK grant. $305,786. PI: Patrick Reichenberger
view source ↗DK grant. $305,786. PI: Patrick Reichenberger
view source ↗
comments(0)
5-min edit window · permanent after that